SEC Form 4 · accession 0001209191-18-005543
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William H Rastetter
Director
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 24, 2018 | M | 20,000 | $7.05 | A | 34,250 | D | |
| Common Stock | Jan 24, 2018 | S | 9,500 | $90.00 | D | 24,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF2 | $7.05 | Jan 24, 2018 | M | 20,000 | A | — | May 25, 2018 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- F2The option was granted May 25, 2011 and vested in 12 equal monthly installments beginning June 25, 2011.